Zimmer Partners, LP Iovance Biotherapeutics, Inc. Transaction History

Zimmer Partners, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$7.78 - $14.19 $3.36 Million - $6.12 Million	431,500 Added 991.95%	475,000 $3.81 Million
Q1 2024 May 15, 2024	SELL	$7.59 - $17.47 $3.43 Million - $7.89 Million	-451,500 Reduced 91.21%	43,500 $644,000
Q4 2023 Feb 14, 2024	BUY	$3.3 - $8.89 $1.63 Million - $4.4 Million	495,000 New	495,000 $4.02 Million

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.35B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Zimmer Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Zimmer Partners, LP with notifications on news.